Reported about 18 hours ago
Molecular diagnostics company BillionToOne Inc. successfully raised $273.1 million in its IPO, selling 4.55 million shares at $60 each despite challenges due to a lengthy US government shutdown. The company's market valuation surpassed $2.6 billion, with co-founders retaining significant voting power post-listing. BillionToOne, known for its non-invasive prenatal screening and liquid biopsy tests, reported a net loss of $4.2 million but improved revenue compared to the previous year.
Source: YAHOO